Feasibility of a Digital Rehabilitation Platform in Patients After ICU Discharge

Recruiting now · Not applicable

Conditions studied: ICU Acquired Weakness (ICUAW)

In brief

This study aims to evaluate the feasibility, usability, and clinical effectiveness of a digital rehabilitation platform in adult patients discharged from the intensive care unit (ICU). Adult patients aged 19 years or older who stayed in the ICU for more than 48 hours and are capable of using a smartphone will be enrolled from two tertiary hospitals in South Korea. Participants will receive individualized rehabilitation programs using a digital rehabilitation platform ("Tuntun Rehabilitation Assistant") based on their functional status. Rehabilitation will be conducted once daily for up to 30 minutes per session. Physical and cognitive function outcomes will be assessed at baseline, two weeks after intervention initiation, at hospital discharge, and during follow-up when applicable. This prospective cohort study will investigate changes in physical function, mobility, cognitive status, and quality of life, as well as platform usage and safety-related events, to determine the clinical usefulness of digital rehabilitation for ICU survivors.

Key facts

Study ID

NCT07489092

Run by

Asan Medical Center

People needed

70

Starts

2026-02-02

Expected to finish

2026-12-31

Last updated by the study team

2026-03-23

Who can join

Age: 19 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age 19 years or older.
• Admission to the intensive care unit (ICU) for more than 48 hours.
• Hospitalization at Asan Medical Center or Seoul National University Bundang Hospital.
• Discharge from the ICU at the time of enrollment.
• Ownership of a smartphone and ability to operate a digital rehabilitation platform.
• Ability to understand the study procedures and provide voluntary written informed consent.

You may not qualify if…

• Medical conditions that contraindicate participation in rehabilitation exercise, as determined by the attending physician.
• Severe cognitive impairment or communication difficulties that interfere with understanding or following study instructions.
• Unstable medical conditions requiring ongoing intensive medical treatment.
• Inability to use a smartphone or digital platform independently.
• Refusal to participate or withdrawal of informed consent.

Where it is running

• Asan Medical Center — Seoul, South Korea (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.